Jon R. Voss, MS Abeona Therapeutics

Jon Voss joined Abeona Therapeutics in October 2021 as Vice President of Quality. Mr. Voss has over 40 years of US and international Quality and Operations expertise in gene/cell therapy, small molecule, biologic and medical device products working as VP of Quality for such companies as Genzyme, Lonza, Sarepta Therapeutics and Cellectis. Having worked in early stage pre-clinical, clinical and commercial organizations, Mr. Voss has unique experience in moving companies from the development to commercial stage. As the former VP of Global Quality, Mr. Voss helped build the Abeona Therapeutics quality organization to support the existing Abeona Therapeutics Phase III EB clinical programs as well as ensuring that Abeona Therapeutics is prepared for commercial licensure and the associated operations.

Mr. Voss earned his Bachelor of Science degree from the University of California at Davis and received his Master of Science in Biomedical Engineering from Boston University.